Can-Fite BioPharma (CANF) Earnings
|
Expand Research on CANF
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +62.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/1/23 | Q123 | $0.00 | -$0.19 | +$0.19 | $196K | N/A | N/A |  | | Details | |
| 3/23/23 | Q422 | N/A | -$0.09 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 11/25/22 | Q322 | -$0.01 | -$0.09 | +$0.08 | $613K | $300K | N/A | | | Details | |
| 8/25/22 | Q222 | -$0.12 | -$0.09 | -$0.03 | $250K | $166.67K | N/A | | | Details | |
11/30/20  |
 |
Q320 | N/A | -$0.24 | N/A | N/A | $250K | N/A | N/A | N/A | |
| 8/27/20 |
|
Q220 | N/A | -$0.33 | N/A | N/A | $250K | N/A | N/A | N/A | |
| 6/1/20 | |
Q120 | -$0.03 | -$0.66 | +$0.63 | $200K | $1.18M | N/A | | | Details |
| 5/27/16 | Q116 | -NIS0.21 | N/A | N/A | NIS214K | N/A | N/A | | | Details |
